Drug interactions
Afatinib + Dabigatran etexilate
Severity: Moderate
Afatinib and Dabigatran etexilate: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Afatinib may inhibit P-glycoprotein and raise dabigatran exposure, increasing bleeding risk.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Afatinib and Dabigatran etexilate interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Dabigatran etexilate
Other interactions of Afatinib
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
